Client Portal Health Plan Partners Billing & Payment Careers Contact Us

UTI Pathogens

Rapid Detection of Urinary Tract Pathogens

HealthTrackRx (HTRx) is the premier specialty diagnostic laboratory dedicated to the detection of infectious diseases.

With a decades-long track record of industry-leading technological advancement, our assays deliver accurate, actionable data with best-in-class turnaround time.

99% of samples received by our lab are reported out within 24-36 hours of receipt.

Eliminate the Guesswork in Diagnosis and Treatment

Our UTI pathogen assay utilizes the latest in quantitative RT-PCR technology to rapidly and reliably analyze your patient’s sample.

We rapidly detect and differentiate 99% of the most relevant bacterial, viral, and fungal targets, eliminating the need for costly, inaccurate, and time-consuming follow up testing.

Our molecular technique provides a more definitive diagnosis than POC antigen assays*

Our UTI Diagnostics:

  • Reduce false negatives
  • Detect polymicrobial infections
  • Are unaffected by concurrent antibiotic use
  • Include one of the most extensive antibiotic resistance gene panels
  • Reduce unnecessary drug exposure and adverse events
  • Report within 24-36 hours of sample receipt

Prescribe with Confidence

As the leader in testing sensitivity and specificity, our reports include a custom-designed accurate and detailed antibiogram.

  • Support antibiotic stewardship by reducing over-utilization of broad-spectrum anti-infectives
  • Decrease the need for empiric therapy
  • Reduce unnecessary drug exposure, adverse events, cost of repeat testing, and multiple treatment attempts

The New 99%

  • Over 99% of results are reported within 24-36 hours of sample receipt

  • Over 99% sensitivity to reduce false positives

  • Over 99% specificity to reduce false positives

  • Over 99% of the most common pathogens detected

  • 100% trackable samples and results

Learn More

(940) 383-2223 | [email protected] | www.healthtrackrx.com

Download UTI Pathogen Testing PDF

UTI Pathogens Profile

  • Acinetobacter baumanii

  • Candida albicans, glabrata, parapsilosis, tropicalis

  • Candida auris

  • Chlamydia trachomatis

  • Citrobacter freundii

  • Escherichia coli

  • Enterobacter aerogenes, cloacae

  • Enterococcus faecalis, faecium

  • Klebsiella pneumoniae, oxytoca

  • Morganella morganii

  • Mycoplasma genitalium, hominus

  • Neisseria gonorrhoeae

  • Proteus mirabilis, vulgaris

  • Pseudomonas aeruginosa

  • Serratia marcescens

  • Staphylcoccus aureus

  • Staphylococcus spp

  • Streptococcus agalactiae (Group B strep (GBS))

  • Streptococcus pyogenes (Group A strep)

  • Trichomonas vaginalis

  • Ureaplasma urealyticum, parvum

Antibiotic Resistance

  • VanA, VanB (Vancomycin resistance)

  • ermB, C; mefA (Macrolide Lincosamide Streptogramin)

  • SHV, KPC Groups (Class A beta lactamase)

  • dfr (A1, A5), sul (1, 2) probes (Trimethoprim/Sulfamethoxazole resistance)

  • mecA (Methicillin gene)

  • qnrA1, qnrA2, qnrB2 (Fluoroquinolone genes)

  • tet B, tet M (Tetracycline genes)

  • IMP, NDM, VIM Groups (Class B metallo beta lactamase)

  • ACT, MIR, FOX, ACC Groups (AmpC beta lactamase)

  • OXA-48,-51 (Class D oxacillinase)

CTX-M1 (15), M2 (2), M9 (9), M8/25 Groups (Class A beta lactamase)

Effective 7/13/2020

*Van der Zee A, Roorda L, Bosman G, Ossewaarde JM (2016) Molecular Diagnosis of Urinary Tract Infections by Semi-Quantitative Detection of Uropathogens in a Routine Clinical Hospital Setting. PLoS ONE 11(3): e0150755. Doi:10.1371/journal.pone.0150755

Learn More

Ready to improve outcomes with fast, accurate diagnostic results? Contact us to learn more.

Click below to schedule your consultation.

Schedule A Consultation